Loading...

Home
Stock
INCY

INCY News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

INCY News

U.S. Jobs and Inflation Data Set for Release

1 day agoCNBC

Wall Street Analysts Adjust Ratings

3 days agoBenzinga

Prelude Therapeutics Receives FDA Clearance for Blood Cancer Trial

5 days agoseekingalpha

Incyte's Cancer Therapy Zynyz Receives EMA Endorsement for New Indication

Jan 30 2026seekingalpha

Incyte Receives Positive EMA Opinion for Zynyz in SCAC Treatment

Jan 30 2026Businesswire

Zynyz® Receives Positive Opinion for SCAC Treatment in Europe

Jan 30 2026Newsfilter

Analysts Downgrade Incyte Target to $107 Amid Market Adjustments

Jan 20 2026Benzinga

BofA Identifies 20 Most Favored Stocks by Hedge Funds

Jan 18 2026seekingalpha

INCY Events

No data

No data

INCY Monitor News

Incyte Corp reaches 5-day high amid market strength

Incyte's Tafasitamab Trial Shows Promising Results

Incyte's Tafasitamab Trial Achieves Key Milestones

Incyte's Tafasitamab Trial Achieves Key Milestones

Incyte's Minjuvi Receives EC Approval for Lymphoma Treatment

Incyte Corp Declines Amid Market Weakness

INCY Earnings Analysis

Incyte Q3 2025 Earnings Report: Dynamic Growth & Focus- Intellectia AI™

Promising Product Growth and Robust Pipeline Ahead - Intellectia AI™

People Also Watch